New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders
By Tarun Sai LomteReviewed by Susha Cheriyedath, M.Sc.Jan 25 2026 An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap faced by people with serious mental illnesses by tackling cardiovascular risk and metabolic disease head-on. Editorial: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons […]
New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders Read More »
